Collins Cynthia — SEC Form 4 filings
SEC reporting owner CIK 1405692. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-23 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | Director | 3 | — | — | 8 |
| Poseida Therapeutics, Inc. (PSTX) | Director | 2 | — | — | 7 |
| MAXCYTE, INC. (MXCT) | Director | 3 | — | — | 6 |
| CODEXIS, INC. (CDXS) | Director | 3 | — | — | 3 |
Form 4 filings — Collins Cynthia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | MAXCYTE, INC. (MXCT) | Grant/award (A): 30,421 @ $0 · Grant/award (A): 49,579 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | CODEXIS, INC. (CDXS) | Grant/award (A): 66,350 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Certara, Inc. (CERT) | Option exercise (M): 15,757 @ $0 · Option exercise (M): 15,757 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | MAXCYTE, INC. (MXCT) | Grant/award (A): 29,210 @ $0 · Grant/award (A): 50,790 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | CODEXIS, INC. (CDXS) | Grant/award (A): 40,983 @ $0 | EDGAR |
| 2025-05-22 | 4 | Certara, Inc. (CERT) | Option exercise (M): 11,928 @ $0 · Option exercise (M): 11,928 (derivative) @ $0 · Grant/award (A): 15,757 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | CODEXIS, INC. (CDXS) | Grant/award (A): 71,174 @ $0 | EDGAR |
| 2025-01-08 | 4 | Poseida Therapeutics, Inc. (PSTX) | Code (U): 58,950 · Disposition to issuer (D): 87,440 (derivative) @ $0 · Disposition to issuer (D): 28,500 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0 | EDGAR |
| 2024-10-16 | 4 | MAXCYTE, INC. (MXCT) | Grant/award (A): 51,679 @ $0 · Grant/award (A): 97,698 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Poseida Therapeutics, Inc. (PSTX) | Grant/award (A): 19,650 @ $0 · Grant/award (A): 27,350 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Certara, Inc. (CERT) | Option exercise (M): 8,663 @ $0 · Option exercise (M): 8,663 (derivative) @ $0 · Grant/award (A): 11,928 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1405692 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →